Form D · Pharmaceuticals

Pharmagen, Inc.

Silver Spring, MD · CIK 0001470915

Offering snapshot reported Aug 23, 2013 · SEC filing

Reported sold
$106K
Offering amount: $106K
Investors reported
1
Form D · investor count
Minimum accepted
$42.5K
Reported outside-investor minimum
First sale
Jun 19, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$52.8K$106KJun 28, 2013: $63,000.00Jun 28, 2013Aug 23, 2013: $105,500.00Aug 23, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$63,000 → $105,500
  • Minimum accepted$63,000 → $42,500

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 23, 2013Amendment$105,500$42,500vs Jun 28, 20131SEC filing
Jun 28, 2013Initial$63,000No comparison1SEC filing
Dec 17, 2012Initial$400,000No comparison1SEC filing

Offering details

Securities
Debt, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-198785
Convertible Promissory Note

Source: Form D, filed Aug 23, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mackie Barch Director, Executive
Eric Clarke Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
9337 Fraser Ave.
Silver Spring, MD, 20910
Phone: (204) 898-8160